Literature DB >> 16682943

MRP-1/CD9 gene transduction regulates the actin cytoskeleton through the downregulation of WAVE2.

C-L Huang1, M Ueno, D Liu, D Masuya, J Nakano, H Yokomise, T Nakagawa, M Miyake.   

Abstract

Motility-related protein-1 (MRP-1/CD9) is involved in cell motility. We studied the change in the actin cytoskeleton, and the expression of actin-related protein (Arp) 2 and Arp3 and the Wiskott-Aldrich syndrome protein (WASP) family according to MRP-1/CD9 gene transduction into HT1080 cells. The frequency of cells with lamellipodia was significantly lower in MRP-1/CD9-transfected HT1080 cells than in control HT1080 cells (P<0.0001). MRP-1/CD9 gene transduction affected the subcellular localization of Arp2 and Arp3 proteins. Furthermore, MRP-1/CD9 gene transduction induced a downregulation of WAVE2 expression (P<0.0001). However, no difference was observed in the expression of Arp2, Arp3 or other WASPs. A neutralizing anti-MRP-1/CD9 monoclonal antibody inhibited downregulation of WAVE2 in MRP-1/CD9-transfected HT1080 cells (P<0.0001), and reversed the morphological effects of MRP-1/CD9 gene transduction. Furthermore, downregulation of WAVE2 by transfection of WAVE2-specific small interfering RNA (siRNA) mimicked the morphological effects of MRP-1/CD9 gene transduction and suppressed cell motility. However, transfection of each siRNA for Wnt1, Wnt2b1 or Wnt5a did not affect WAVE2 expression. Transfection of WAVE2-specific siRNA also did not affect expressions of these Wnts. These results indicate that MRP-1/CD9 regulates the actin cytoskeleton by downregulating of the WAVE2, through the Wnt-independent signal pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682943     DOI: 10.1038/sj.onc.1209654

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  Tetraspanins and tumor progression.

Authors:  Mekel M Richardson; Lisa K Jennings; Xin A Zhang
Journal:  Clin Exp Metastasis       Date:  2010-12-24       Impact factor: 5.150

2.  Establishment of human trophoblast progenitor cell lines from the chorion.

Authors:  Olga Genbacev; Matthew Donne; Mirhan Kapidzic; Matthew Gormley; Julie Lamb; Jacqueline Gilmore; Nicholas Larocque; Gabriel Goldfien; Tamara Zdravkovic; Michael T McMaster; Susan J Fisher
Journal:  Stem Cells       Date:  2011-09       Impact factor: 6.277

Review 3.  Tetraspanins: push and pull in suppressing and promoting metastasis.

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

4.  Emerging roles of tetraspanins in plant inter-cellular and inter-kingdom communication.

Authors:  Saul Jimenez-Jimenez; Kenji Hashimoto; Olivia Santana; Jesús Aguirre; Kazuyuki Kuchitsu; Luis Cárdenas
Journal:  Plant Signal Behav       Date:  2019-03-04

5.  Regulation of the actin cytoskeleton in cancer cell migration and invasion.

Authors:  Hideki Yamaguchi; John Condeelis
Journal:  Biochim Biophys Acta       Date:  2006-07-14

6.  ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.

Authors:  Masaki Nagata; Arhab A Noman; Kenji Suzuki; Hiroshi Kurita; Makoto Ohnishi; Tokio Ohyama; Nobutaka Kitamura; Takanori Kobayashi; Kohya Uematsu; Katsu Takahashi; Naoki Kodama; Tomoyuki Kawase; Hideyuki Hoshina; Nobuyuki Ikeda; Susumu Shingaki; Ritsuo Takagi
Journal:  BMC Cancer       Date:  2013-09-05       Impact factor: 4.430

Review 7.  Tetraspanin CD9: A friend or foe of head and neck cancer (Review).

Authors:  Suhasini P C; Shilpa S Shetty; Suchetha Kumari Nalilu; Praveen Kumar Shetty; Prakash Patil
Journal:  Oncol Rep       Date:  2022-03-10       Impact factor: 3.906

8.  CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.

Authors:  Ariel A Williams; John P T Higgins; Hongjuan Zhao; Börje Ljunberg; James D Brooks
Journal:  BMC Clin Pathol       Date:  2009-11-18

9.  Role of motility-related protein-1 in promoting the development of several types of cancer (Review).

Authors:  Han Xuan; Xiaotong Hu; Jinwen Huang
Journal:  Oncol Lett       Date:  2014-01-09       Impact factor: 2.967

10.  CD9 negatively regulates CD26 expression and inhibits CD26-mediated enhancement of invasive potential of malignant mesothelioma cells.

Authors:  Toshihiro Okamoto; Satoshi Iwata; Hiroto Yamazaki; Ryo Hatano; Eriko Komiya; Nam H Dang; Kei Ohnuma; Chikao Morimoto
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.